## **Core Concept**
Richner-Hanhart syndrome, also known as tyrosinemia type II, is a rare genetic disorder caused by a deficiency of the enzyme **tyrosine aminotransferase**. This enzyme is crucial for the breakdown of the amino acid tyrosine. The condition leads to elevated levels of tyrosine in the blood and other bodily fluids.

## **Why the Correct Answer is Right**
The correct answer indicates a decrease or low level of plasma tyrosine. In Richner-Hanhart syndrome, despite the overall increase in tyrosine due to the enzyme deficiency, the specific answer choice pointing to a decrease or low level might seem counterintuitive. However, the disorder indeed results in **elevated tyrosine levels** in the plasma due to the impaired degradation pathway. The question seems to have a discrepancy, but based on the typical understanding of the disorder, one would expect **increased** tyrosine levels. The question's framing might be testing understanding of specific biochemical pathways and disorders.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option suggests an increase, which aligns with the expected biochemical abnormality in Richner-Hanhart syndrome (elevated tyrosine levels).
- **Option B:** This option might suggest a normal level, which does not accurately reflect the metabolic defect seen in Richner-Hanhart syndrome.
- **Option D:** This option could imply a significant alteration but is not directly addressed due to the focus on the provided correct answer.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that Richner-Hanhart syndrome presents with **ocular, skin, and neurological symptoms** and is associated with **elevated plasma tyrosine levels** due to tyrosine aminotransferase deficiency. This condition highlights the importance of amino acid metabolism in human health.

## **Correct Answer:** .